In October, we examined the uncertain future of 23andMe, a company that helped popularize direct-to-consumer genetic testing. On Sunday, the company filed for bankruptcy and announced the resignation of its founder, Anne Wojcicki. The bankruptcy raises urgent questions about the privacy of sensitive DNA data provided by more than 15 million customers. Since the data isn’t protected by health-privacy laws, it’s unclear what that would mean for people who have used 23andMe. For example, insurance companies could buy and Continue reading